This content is machine translated Treatment resistant depression Esketamine nasal spray as monotherapy? New for treatment-resistant depression Despite a variety of approved antidepressant treatments, major depressive disorder (MDD) remains one of the leading causes of disability worldwide and has been shown to shorten the life expectancy of...…
View Post 3 min This content is machine translated Treatment resistant depression Esketamine nasal spray: new mechanism of action fuels hope When patients with moderate to severe depression do not respond to two different antidepressants, further therapeutic options have been very limited. With approval of the new esketamine nasal spray, there…
View Post 2 min This content is machine translated Majore depression Ketamine-containing nasal spray approved in Switzerland Following the EU, Switzerland has also recently approved a nasal spray based on the active ingredient ketamine, which is known as a party drug. The preparation can be used as…
